The infrastructure moment for AI-driven drug discovery continues to accelerate, with billion-dollar investments flowing into ...

Researchers from University of Arizona present a new therapeutic target to shield nerve cells from the damage of ALS.

This eBook explores how researchers can move beyond correlation and towards mechanism in microbiome research—from preserving physiologically relevant microbial communities to directly measuring ...